the FDA considers new vaccines and says
selecting an updated vaccine is complex, the staff said, because there are “multiple uncertainties, including the future course of virus evolution, the lack of clinical efficacy data compared with earlier prototype vaccines, and potential manufacturing issues that might arise related to producing an updated vaccine formulation.”
So we have no good data but we have a hunch maybe it increases antibody levels, plus Biden says he owes Pfizer so we’re gonna endorse it anyway. Speaking of which, here’s over $3B of your taxpayer dollars walking out the door to buy kids vaccines and O-specific vaccines for something 2-3 variants old (“Omicron classic”) that most people already got exposed to.
The U.S. government will pay the companies $3.2 billion upon receipt of the first 105 million doses.
And if you think slow walking their data into the 2020 election was sold cheap, don’t forget the government can buy more and blow up to $10B on this round of extra vaccines.
Under this agreement, the U.S. government also has the option to purchase up to 195 million additional doses, bringing the total number of potential doses to 300 million.